PDTC promotes wound healing in STZ-reduced diabetic mice by mesenchymal stem cells
|更新时间:2025-01-15
|
PDTC promotes wound healing in STZ-reduced diabetic mice by mesenchymal stem cells
Journal of Army Medical UniversityVol. 35, Issue 21, Pages: 2325-2330(2013)
作者机构:
1. 第三军医大学:西南医院整形美容科,药学院临床血液学教研室
2. 乌鲁木齐总医院泌尿外科
3. 解放军第474医院整形外科
作者简介:
基金信息:
DOI:
CLC:R640.5;R587.1;R977.6
Published:2013,
Published Online:15 November 2013,
稿件说明:
移动端阅览
ZHANG YULONG, WU JULONG, GAO XIAOKANG, et al. PDTC promotes wound healing in STZ-reduced diabetic mice by mesenchymal stem cells. [J]. Journal of army medical university, 2013, 35(21): 2325-2330.
DOI:
ZHANG YULONG, WU JULONG, GAO XIAOKANG, et al. PDTC promotes wound healing in STZ-reduced diabetic mice by mesenchymal stem cells. [J]. Journal of army medical university, 2013, 35(21): 2325-2330.DOI:
PDTC promotes wound healing in STZ-reduced diabetic mice by mesenchymal stem cells
Objective To investigate the role of special inhibitor of NF-κB pathway
pyrrolidine dithiocarbamate (PDTC)
in wound healing by transplanting bone marrow mesenchymal stem cells (MSCs) in STZ-reduced diabetic mice. Methods The bone marrow MSCs from GFP transgenic mice were iso
lated and cultured. For C57BL/6 mice
diabetes was induced by multiple low-dose of STZ (50 mg/kg injection i.p
once a day for 5 consecutive days). A round dorsal skin defect
in a diameter of 6 mm
was made in the mice model. The experimental animals were divided into 4 groups
that is
normal control
diabetic control group
MSCs treatment group (receiving 2.5×10
5
MSCs per dose in 8 areas surrounding wound margin)
MSCs+PDTC group (receiving 2.5×10
5
MSCs and injection i.p of PDTC). Wound healing was observed in 3
7
11
and 14 d after operation
and wound tissue was cut and observed by HE staining and immunohistochemical assay. Results The wound healing rate was significantly higher in MSCs+PDTC group than in MSCs treatment group and diabetic control group(
P
<
0.05). HE staining indicated that there was better vascular formation in the former than the 2 later groups. Immunohistochemical assay showed VEGF was expressed in MSCs+PDTC group (33.51±2.40) in 11 d after operation
significantly strongly than those in MSCs treatment group (18.71±7.14) and diabetic control group(26.07±4.50
P
<
0.05). While the expression of NF-kappa B expression was significantly reduced in MSCs+PDTC group (35.20±18.77)than in MSCs treatment group (56.80±16.35)and diabetic control group(130.64±16.35
P
<
0.05). On the 14th day
GFP fluorescence signal was significantly stronger in MSCs+PDTC group(135.20±11.84) than in MSCs treatment group (46.81±22.37
P
<
0.05). Conclusion PDTC could promote wound healing in diabetic mice treated with bone marrow MSCs by blocking NF-kappaB pathway.
Department of Endocrinology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Plastic and Burn Surgery, Laboratory of Wound Repair and Regeneration of National Key Clinical Construction Specialty, Affiliated Hospital of Southwest Medical University
Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension, Daping Hospital, Army Medical University (Third Military Medical University)